AYUSH vs FSSAI is one of the most critical regulatory crossroads for hemp, CBD, nutraceuticals, and herbal wellness products in India today. In 2026, the distinction determines whether your product is treated as a “food supplement” under FSSAI or as a “traditional medicine” under AYUSH — with direct implications for licensing, compliance, and market access.

Introduction

India’s hemp and CBD industry is expanding rapidly, but regulatory clarity remains fragmented. Entrepreneurs, importers, and wellness brands often struggle to decide: Should my product go under FSSAI or AYUSH? This blog breaks down the differences, market trends, and global context to help Hemplogy readers navigate compliance.

FSSAI: Food & Nutraceutical Route

Key Features

  • Regulator: Food Safety and Standards Authority of India (FSSAI)
  • Scope: Foods, beverages, nutraceuticals, health supplements, functional foods
  • Licensing: FoSCoS system, typically valid for 1–5 years
  • Ingredient Approval: Must be listed in schedules or approved as “novel food”
  • CBD Challenge: CBD is not explicitly permitted as a food ingredient; requires novel food approval

Pros

  • Easier entry for protein powders, hemp seeds, hemp oil
  • Stronger alignment with Amazon bestsellers (CBD gummies, hemp protein)
  • International credibility for exports

Cons

  • Ingredient restrictions (CBD, cannabinoids)
  • Heavy compliance audits for imports

AYUSH: Traditional Medicine Route

Key Features

  • Regulator: Ministry of AYUSH
  • Scope: Ayurveda, Yoga, Unani, Siddha, Homoeopathy (ASU drugs)
  • Licensing: State-level AYUSH authorities under Drugs & Cosmetics Act
  • Positioning: Products must fit therapeutic claims with permitted plant parts

Pros

  • Easier acceptance for herbal formulations and Ayurvedic hemp remedies
  • Strong domestic market appeal (India’s herbal wellness boom)
  • Leverages India’s cultural heritage

Cons

  • Requires therapeutic positioning (not “general wellness”)
  • Limited global acceptance compared to FSSAI

📊 Comparison Table

AspectFSSAIAYUSH
RegulatorFood Safety and Standards Authority of IndiaMinistry of AYUSH
Product TypeFoods, supplements, nutraceuticalsASU drugs, herbal remedies
LicensingFoSCoS, 1–5 yearsState AYUSH authorities
CBD/HempRestricted, novel food approval neededAllowed if framed as Ayurvedic
Market FitAmazon bestsellers, global exportsDomestic herbal wellness
RiskIngredient bans, import auditsNDPS Act sensitivities

🌍 Global & Regional Insights

  • India: Hemp seeds/oils fit FSSAI; CBD wellness often routed via AYUSH.
  • UK: CBD supplements regulated as “novel foods.”
  • US: FDA treats CBD as restricted in food but allowed in cosmetics.
  • Amazon Trends: CBD gummies, hemp protein powders, organic hemp supplements India dominate searches.

Q1: Is CBD legal under FSSAI in India? CBD is not explicitly permitted as a food ingredient; requires novel food approval.

Q2: Can hemp oil be sold under AYUSH? Yes, if positioned as Ayurvedic medicine with therapeutic claims.

Q3: Which route is better for exports? FSSAI licensing aligns better with international food standards.

Q4: Does NDPS Act affect hemp products? Yes, narcotics law applies if THC levels exceed permissible limits.

Q5: What products fit FSSAI vs AYUSH?

  • FSSAI: Hemp protein, hemp seeds, hemp oil (food use)
  • AYUSH: Ayurvedic hemp remedies, herbal tinctures

Navigating AYUSH vs FSSAI is not just a compliance decision — it defines your brand’s market positioning. For hemp entrepreneurs, the safest path is to map products carefully: foods under FSSAI, remedies under AYUSH.

👉 Visit Hemplogy for more encyclopedia entries, share this article with your network, and explore our cornerstone guides on hemp regulation.

Share the hemp wisdom